Introduction
Moyamoya disease is a progressive disorder of the blood vessels at the base of the brain, in which the major arteries that supply the brain gradually narrow or become blocked. As this happens, the brain responds by forming a network of tiny collateral vessels that try to restore blood flow. On angiographic imaging, these vessels can look like a hazy cloud, which is the origin of the term “moyamoya,” a Japanese word meaning something like “puff of smoke.” The condition mainly involves the cerebral circulation, especially the internal carotid arteries and their major branches.
The disease is defined by chronic arterial narrowing and the body’s attempt to compensate through abnormal vessel growth. Understanding Moyamoya disease requires looking at both the loss of normal blood supply and the vascular remodeling that follows. The process is not simply a blockage in one vessel; it is a progressive change in the structure and function of the brain’s arterial network.
The Body Structures or Systems Involved
Moyamoya disease primarily affects the intracranial arteries, especially the terminal portions of the internal carotid arteries and the proximal segments of the anterior and middle cerebral arteries. These vessels are part of the arterial system that delivers oxygenated blood to the brain. In a healthy person, these arteries provide stable, high-flow circulation to brain tissue, which depends on a constant supply of oxygen and glucose because it has very limited energy reserves.
The condition also involves the smaller collateral vessels that develop in response to reduced blood flow. These are not the normal, efficient arteries that the brain uses in healthy circulation. Instead, they are fragile networks of tiny vessels arising from deep brain structures and nearby arteries. The brain’s autoregulatory system, which normally adjusts vessel diameter to preserve cerebral perfusion, is also affected because the narrowing vessels limit the ability to compensate for changing blood demand.
In some cases, the systemic vascular environment and the layers of the arterial wall are relevant as well. The inner lining of the artery, or endothelium, and the smooth muscle within the vessel wall play key roles in maintaining arterial tone and structure. In Moyamoya disease, these components undergo abnormal remodeling that gradually changes the vessel lumen and the vessel wall architecture.
How the Condition Develops
The development of Moyamoya disease begins with progressive narrowing of the large arteries at the base of the brain. The exact trigger is not always known, but the disease reflects an active biological process rather than simple passive clogging. Histologic studies show changes in the arterial wall, including thickening of the intimal layer, reduction or alteration of smooth muscle cells, and irregularity of the internal elastic lamina. These changes reduce the diameter of the vessel lumen and restrict blood flow to downstream brain tissue.
As the main arterial supply becomes limited, local blood flow pressure drops. The brain responds by activating collateral circulation. Small vessels enlarge or new channels form from surrounding arteries to bypass the narrowed segments. This compensation is an adaptive response to chronic ischemia, but in Moyamoya disease the resulting vessels are unusually numerous, tortuous, and fragile. They provide partial compensation for reduced flow, but they are not a fully normal substitute for the original arterial supply.
The narrowing often progresses over time. As the primary vessels become more stenotic, perfusion pressure in the brain decreases further, increasing dependence on collateral vessels. This creates a cycle in which worsening stenosis leads to increasing collateral formation, but the collateral network itself may still be insufficient to meet the metabolic needs of brain tissue. The disease therefore develops as a dynamic mismatch between cerebral oxygen demand and compromised vascular delivery.
Inflammation is not the dominant feature in the way it is in some vasculitides, but biologic signals that regulate vessel growth and remodeling likely contribute. Abnormal endothelial behavior, altered growth factor signaling, and dysregulated repair responses have all been implicated in the disease process. In some patients, a genetic predisposition appears to make the arterial wall more vulnerable to this pattern of progressive remodeling.
Structural or Functional Changes Caused by the Condition
The most important structural change in Moyamoya disease is stenosis, or marked narrowing, of the major intracranial arteries. This narrowing reduces the caliber of the vessels and lowers the amount of blood that can reach brain tissue. In advanced stages, portions of the internal carotid circulation may become severely compromised or completely occluded.
Functionally, the brain experiences reduced cerebral perfusion reserve. In a healthy circulation, vessels can dilate to increase blood delivery when demand rises, such as during physical activity, fever, or changes in breathing. In Moyamoya disease, this reserve is limited because the major arteries are already narrowed and the compensatory collaterals have little ability to expand further. As a result, the brain becomes more vulnerable to transient or sustained periods of insufficient blood flow.
The collateral vessels themselves represent another important change. These vessels are a sign that the body is responding to chronic ischemic stress, but they are structurally abnormal. They are thin-walled, disorganized, and prone to rupture in some circumstances. Their presence can also create altered hemodynamics, with turbulent flow and uneven distribution of blood. This means that while they may preserve some circulation, they do not recreate the stable, high-capacity flow of the original large arteries.
In addition to reduced flow, the disease alters the balance between oxygen delivery and tissue demand. Brain regions supplied by the affected arteries may operate near the threshold of ischemia. This can cause the tissue to function in a precarious state, especially in areas where collateral coverage is incomplete. Over time, repeated or prolonged hypoperfusion can damage neurons and supporting cells, affecting the integrity of brain networks.
Factors That Influence the Development of the Condition
Genetic factors are among the strongest influences on Moyamoya disease. The condition can occur sporadically, but certain gene variants are associated with increased susceptibility. One of the best studied is RNF213, which has been linked to a higher risk of Moyamoya disease in several populations. This does not mean that a single gene fully causes the disorder; rather, it suggests that inherited differences in vascular development or remodeling may make the arteries more likely to undergo the characteristic narrowing.
Ethnic background also influences risk, with higher prevalence reported in East Asian populations, though the disease occurs worldwide. This pattern supports the idea that genetic susceptibility varies across populations. Familial cases, in which more than one family member is affected, further indicate that inherited factors can shape the disease process.
Some cases occur as Moyamoya syndrome, meaning the vascular pattern is associated with another condition such as Down syndrome, neurofibromatosis type 1, sickle cell disease, prior cranial radiation, or certain autoimmune disorders. In these settings, the arterial changes may arise from different upstream mechanisms, but they converge on a similar final pathway of stenosis and collateral formation. For example, radiation can injure the vessel wall, while sickle cell disease can alter blood flow and endothelial function. The resulting biology still centers on progressive compromise of the cerebral arteries.
Age may influence how the disease presents and progresses. In children, the developing brain and changing metabolic demands can make reduced perfusion more consequential. In adults, vascular remodeling may be slower or may be discovered after a different cerebrovascular event. Hormonal or environmental influences may modify vascular behavior, but the most established drivers remain genetic susceptibility and associated medical conditions that affect cerebral vessels.
Variations or Forms of the Condition
Moyamoya disease can be classified as either primary disease or secondary Moyamoya syndrome. Primary disease refers to the characteristic progressive arterial narrowing without an identified associated condition. Secondary forms show the same angiographic pattern but occur in the context of another disorder. Although the vascular appearance may be similar, the underlying cause of vessel injury or remodeling may differ.
The condition also varies by stage and extent. Early disease may involve mild narrowing with limited collateral development, while more advanced disease shows severe stenosis or occlusion and a dense collateral network. In some patients the disease is more unilateral at first, affecting one side of the brain more prominently, while in others it becomes bilateral. Bilateral involvement is classically associated with the diagnosis, but asymmetric or evolving disease can occur.
There are also differences in the balance between ischemic and hemorrhagic risk. Some patients mainly experience reduced perfusion because the collateral circulation is inadequate. Others develop complications related to rupture of fragile collateral vessels or other abnormal vascular channels. These differences reflect variation in vessel fragility, pressure dynamics, and the architecture of the collateral network.
Pediatric and adult disease can appear as different functional forms of the same disorder. In children, the narrower vessels and limited perfusion reserve may more readily produce ischemic stress. In adults, longstanding abnormal vessels and collateral networks may persist for years, with different hemodynamic consequences. The core mechanism remains the same, but the pattern of vascular adaptation and tissue response can differ.
How the Condition Affects the Body Over Time
Because Moyamoya disease is progressive, the body often adapts in ways that partially offset reduced blood flow, but these adaptations have limits. Over time, the arterial narrowing can reduce the safety margin for cerebral perfusion. Brain tissue may continue to receive enough blood at rest yet become vulnerable during periods when demand rises or systemic blood pressure falls. This reduced reserve is one of the defining physiological consequences of the disease.
Chronic hypoperfusion can lead to repeated stress on neurons and glial cells. Brain tissue that does not receive adequate oxygen and glucose cannot sustain normal electrical and metabolic activity. Recurrent metabolic strain can impair local brain function and increase the risk of tissue injury if circulation drops further. The brain may recruit more collateral channels, but these channels are often insufficient to fully restore normal hemodynamics.
As the disease advances, the collateral vessels themselves can become a source of instability. Their fragility and abnormal flow patterns may predispose them to bleeding in some patients, especially when pressure is redistributed through small, thin-walled channels. The disease therefore can produce both ischemic and hemorrhagic consequences, depending on which vascular adaptations dominate.
Long-term, Moyamoya disease can reshape cerebral circulation in a profound way. Instead of a few large, efficient arteries supplying the brain, blood flow becomes increasingly dependent on a complex and imperfect web of alternate pathways. This can preserve life-sustaining perfusion for a period of time, but it does so at the cost of efficiency, stability, and vascular resilience. The disease is therefore best understood as a chronic failure of normal cerebrovascular architecture, accompanied by a compensatory but imperfect attempt at repair.
Conclusion
Moyamoya disease is a progressive cerebrovascular disorder marked by narrowing of the major arteries that supply the brain and the formation of abnormal collateral vessels. Its defining features are structural remodeling of the intracranial arterial walls, reduced cerebral blood flow, and the development of fragile alternate circulation. The condition reflects an interaction between vascular biology, genetic susceptibility, and the brain’s need to preserve perfusion despite obstruction.
Understanding Moyamoya disease at the level of anatomy and physiology explains why it behaves as it does. The disease is not simply a blocked artery; it is a dynamic process in which arteries narrow, collateral vessels emerge, and cerebral blood delivery becomes increasingly dependent on abnormal compensation. This framework provides the basis for understanding its later symptoms, diagnostic findings, and management in separate discussions.